ArticleApplied immunohistochemistry & molecular morphology : AIMM2026

MHC Class I and PD-L1 Expression May Predict Treatment Response to Anti-PD-1/PD-L1 Therapy in Metastatic Triple-negative Breast Cancer Patients.

Joseph L Maniaci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.